Journals / Turkish Journal of Gastroenterology / 2000 / Cilt: 11 - Sayı: 1

Ratlarda etanol ve asetaminofen toksisitesinde lipid peroksitleri, glutatyon ve antiperoksidatif

Significance of lipid peroxides, glutathione and antiperoxidative enzymes in ethanol and acetaminophen toxicity in the rat

Pages
54–60
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Other antiperoxidative enzymes, SOD and catalase activities were increased in both short and long term ethanol, acetaminophen or ethanol+acetaminophen administration.The results suggest that both ethanol and acetaminophen modulates exhibit their hepatotoxicity by increasing free radical formation.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Malondialdehyde (MDA) content (an indicator of lipid peroxidation) in the liver, kidney, heart and brain, glutathione (GSH) and glutathione peroxidase (GSH-Px) activities in liver, superoxide dismutase (SOD) and catalase activities in erythrocyte, aspartate transaminase (AST), alanine transaminase (ALT) and alkaline phosphatase (ALP) levels in sera of rats was measured.
📊
Key Findings & Data:The rats were given 18% ethanol and acetaminophen for a period of between 30 and 90 days.
💡
Conclusion & Impact:Other antiperoxidative enzymes, SOD and catalase activities were increased in both short and long term ethanol, acetaminophen or ethanol+acetaminophen administration.The results suggest that both ethanol and acetaminophen modulates exhibit their hepatotoxicity by increasing free radical formation.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Etanol · Alkol zehirlenmesi · Katalaz

Abstract

Malondialdehyde (MDA) content (an indicator of lipid peroxidation) in the liver, kidney, heart and brain, glutathione (GSH) and glutathione peroxidase (GSH-Px) activities in liver, superoxide dismutase (SOD) and catalase activities in erythrocyte, aspartate transaminase (AST), alanine transaminase (ALT) and alkaline phosphatase (ALP) levels in sera of rats was measured. The rats were given 18% ethanol and acetaminophen for a period of between 30 and 90 days. A significant increase was observed in the serum ALT, AST and ALP levels, depending on the degree of liver injury in the rat groups (normal, normal+acetaminophen, 18% ethanol and 18% ethanol+acetaminophen). The MDA levels in liver, heart, kidney and brain were increased in the short and long-term (30 and 90 days respectively) ethanol and acetaminophen treated rats. GSH levels decreased in the rats compared to normal rats, administered with ethanol or acetaminophen for 30 days, compared to normal rats, while they increased in the 90 days. Ethanol or acetam inophen+ethanol administration caused a decrease in GSH levels when compared with ethanol control rats. It was observed that liver GSH-Px activity was increased in the short and long-term ethanol or acetaminophen treated rats, compared to normal rats. Short and long term acetaminophen+ethanol administration increased the liver GSH-Px activities in comparison with ethanol control rats. Other antiperoxidative enzymes, SOD and catalase activities were increased in both short and long term ethanol, acetaminophen or ethanol+acetaminophen administration.The results suggest that both ethanol and acetaminophen modulates exhibit their hepatotoxicity by increasing free radical formation. The consequent changes occuring in the activities of antiperoxidative enzymes may expose the cell to the destructive effects of oxidative stress.

Özet

Otuz ve 90 günlük periyotlarla %18 etanol ve paracetamol (asetaminofen) uyguladığımız 80 rat'ın böbrek, beyin, kalp ve karaciğerlerinde, lipid peroxidasyonunun bir göstergesi olan Malondialdehid (MDA) düzeylerini, karaciğerlerinde glutatyon (GSH), glutatyon peroksidaz (GSH-Px) aktivitelerini, eritrositlerinde süperoksid dismutaz (SOD) ve Katalaz aktiviteleriyle serum transaminazlarından Aspartat Transaminaz (AST), Alanin Transaminaz (ALT) ve Alkalen fosfataz (ALP) düzeylerini araştırdık. Gruplara ayırdığımız (Normal, normal+asetaminofen, %18 Etanol ve %18 etanol+asetaminofen) ratlarda, karaciğer hasarına bağlı olarak önemli miktarda artmış serum ALT, AST ve ALP düzeyleri saptadık. MDA düzeyleri, karaciğer, kalp, böbrek ve beyin dokusunda hem kısa (30 gün) hem de uzun dönem (90 gün) etanol ve asetaminofen uygulanmış ratlarda artmıştı.GSH düzeyleri 30 gün etanol veya asetaminofen uygulanmış ratlarda normal kontrollere göre azalmış iken, 90 gün uygulananlarda artmıştı. Ancak, etanol kontrol ratlarıyla karşılaştırıldığında 90 gün asetaminofen+etanol uygulaması glutatyon düzeylerinde bir azalışa neden oldu. Karaciğer GSH-Px aktivitesi, 30 ve 90 gün yalnız etanol veya asetaminofen uygulanmış ratlarda normal ratlara göre artarken, etanol kontrol ratlara göre asetaminofen+etanol uygulananlarda da artış olduğu gözlendi. Diğer antiperoxidatif enzimlerden, süperoksid dismutaz (SOD) ve katalaz aktiviteleri her iki dönemde de etanol; asetaminofen; etanol+asetaminofen grubu ratlarda azalmıştı. Sonuçlar, hem kısa hem de uzun süre alkol ve asetaminofen alımının karaciğer ve extrahepatik dokularda biyokimyasal değişikliklerle sonuçlandığını göstermektedir. Bu da, alkolizm ve ilaç toksisitesinde antiperoxidatif enzimlerin akti-vitelerindeki değişikliklere, artmış eikosanoidlerin sentezi, artmış lipid peroksidasyonu ve buna bağlı doku hasarının neden olduğunu düşündürmektedir.

🔖

Cite This Article

ATAMER, Y., KOÇYİĞİT, Y., ATAMER, A., METE, N., CANORUÇ, N. (2000). Ratlarda etanol ve asetaminofen toksisitesinde lipid peroksitleri, glutatyon ve antiperoksidatif. Turkish Journal of Gastroenterology, Cilt: 11 - Sayı: 1, 54–60. https://ajindex.com/articles/410459

References (2)

  1. . Kappas H, Sies H. Toxic drug effects associated with oxygen metabolism: redox cycling and lipid peroxidation. Experientia 1981; 37: 1233-41. 2). Lauterburg BH, Velez ME. Glutathione deficiency in alcoholics:risk factor for acetaminophen hepatotoxicity. Gut 1988; 29: 1153-7. 3). Aaseth J, Smith-Kielland A, Thomassen Y. Selenium, alcohol and liver diseases. Ann Clin Res 1986; 18: 43-7. 4). Emby DJ, Fraser BN. Hepatotoxicity of acetaminophen enhanced by ingestion of alcohol. S Afr Med J 1977; 51: 208-9. 5). Jaya DS, Augstine J and Menon VP. Role of lipid peroxides, glutathione and antiperoxidative enzymes in alcohol and drug toxicity. Ind J Exp Biol 1983; 31: 453-9. 6). Videla LA and Valenzuela A. Alcohol ingestion, liver glutathione and lipoperoxidation: metabolic interrelations and pathological implications. Life Sci 1982; 31: 2395-2407. 7). Speisky H, Bunout D, Orrego H, Israel Y. Lack of changes in diene conjugate levels following ethonol induced glutathione depletion or hepatic necrosis. Res Commun Chem Pathol Pharmacol 1985; 48: 77-90. 8). Inomata T, Rao GA, Tsukamoto H. Lack of evidence for increased lipid peroxidation in ethanol-induced centrilobuler necrosis of rat liver. Liver 1987; 7: 233-9. 9). Ohkawa H, Oh_sh_ N and Yagi N. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351-8. 10). Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1959; 82: 70-7. 11). Hafeman DG, Sunde RA, Hoekstra WG. Effect of dietary selenium on erythrcyte and liver glutathione peroxidase in the rat. J Nutr 1974; 104: 580-7. 12). Winterbourn CC, Hawkins RE, Brian M, Carrell RW. The estimation of red cell superoxide dismutase activity. J Lab Clin Med 1975;85:337. 13). Aebi H. Catalase in vitro. Methods in enzymology 1984; 105: 121. 14). Esterbauer H. Aldehydic products of lipid peroxidation, in: "Free radicals, lipid peroxidation and cancer. Eds: D.C.H. Mc Brien and T.F. Slater 1982;101-128,
  2. Academic Press, London. 15). Suematsu T, Matsumura T, Sato N, et al. Lipid peroxidation in alcoholic liver disease in humans. Alcohol Clin Exp Res 1981;5:427-30. 16). Kamimura S, Gaal K, Britton RS, et al. Increased 4-hydroxynonenal levels in experimental alcoholic liver disease: association of lipid peroxidation with liver fibrogenesis. Hepatology 1992; 16: 448-53. 17). Lieber CS. Metabolism and metabolic effects of alcohol. Semin Hematol 1980;17:85-99. 18). Teschke R, Hasumura Y and Lieber CS. Hepatic pathw